» Articles » PMID: 31461342

Identification of the Intermediate Filament Protein Synemin/SYNM As a Target of Myocardin Family Coactivators

Overview
Specialties Cell Biology
Physiology
Date 2019 Aug 29
PMID 31461342
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Myocardin (MYOCD) is a critical regulator of smooth muscle cell (SMC) differentiation, but its transcriptional targets remain to be exhaustively characterized, especially at the protein level. Here we leveraged human RNA and protein expression data to identify novel potential MYOCD targets. Using correlation analyses we found several targets that we could confirm at the protein level, including SORBS1, SLMAP, SYNM, and MCAM. We focused on , which encodes the intermediate filament protein synemin. rivalled smooth muscle myosin () for SMC specificity and was controlled at the mRNA and protein levels by all myocardin-related transcription factors (MRTFs: MYOCD, MRTF-A/MKL1, and MRTF-B/MKL2). MRTF activity is regulated by the ratio of filamentous to globular actin, and was accordingly reduced by interventions that depolymerize actin, such as latrunculin treatment and overexpression of constitutively active cofilin. Many MRTF target genes depend on serum response factor (SRF), but lacked SRF-binding motifs in its proximal promoter, which was not directly regulated by MYOCD. Furthermore, resisted SRF silencing, yet the time course of induction closely paralleled that of the SRF-dependent target gene . was repressed by the ternary complex factor (TCF) FLI1 and was increased in mouse embryonic fibroblasts lacking three classical TCFs (ELK1, ELK3, and ELK4). Imaging showed colocalization of SYNM with the intermediate filament proteins desmin and vimentin, and MRTF-A/MKL1 increased SYNM-containing intermediate filaments in SMCs. These studies identify SYNM as a novel SRF-independent target of myocardin that is abundantly expressed in all SMCs.

Citing Articles

Elucidating the roles of SOD3 correlated genes and reactive oxygen species in rare human diseases using a bioinformatic-ontology approach.

Stanworth M, Zhang S PLoS One. 2024; 19(10):e0313139.

PMID: 39480826 PMC: 11527182. DOI: 10.1371/journal.pone.0313139.


Spatial multiomics atlas reveals smooth muscle phenotypic transformation and metabolic reprogramming in diabetic macroangiopathy.

Qian Y, Xiong S, Li L, Sun Z, Zhang L, Yuan W Cardiovasc Diabetol. 2024; 23(1):358.

PMID: 39395983 PMC: 11471023. DOI: 10.1186/s12933-024-02458-x.


Suppression of smooth muscle cell inflammation by myocardin-related transcription factors involves inactivation of TANK-binding kinase 1.

Bankell E, Liu L, van der Horst J, Rippe C, Jepps T, Nilsson B Sci Rep. 2024; 14(1):13321.

PMID: 38858497 PMC: 11164896. DOI: 10.1038/s41598-024-63901-3.


CD146, a therapeutic target involved in cell plasticity.

Wu Z, Zang Y, Li C, He Z, Liu J, Du Z Sci China Life Sci. 2024; 67(8):1563-1578.

PMID: 38613742 DOI: 10.1007/s11427-023-2521-x.


Influence of DNA Methylation on Vascular Smooth Muscle Cell Phenotypic Switching.

Yorn C, Kim H, Jeong K Int J Mol Sci. 2024; 25(6).

PMID: 38542110 PMC: 10969885. DOI: 10.3390/ijms25063136.